Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2020

Jul 23, 2020

29777_dirs_2020-07-23_3226f0e6-28e2-4089-84ad-57a19a1a1430.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2020-07-21

Reporting Person: PEDERSON MICHAEL J (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-07-21 Common shares without par value M 23008 Acquired 96899 Direct
2020-07-21 Common shares without par value S 23008 $98 Disposed 73891 Direct
2020-07-21 Common shares without par value F 2437 $99.08 Disposed 71454 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-07-21 Option (right to buy) $50.72 M 23008 Disposed 2027-07-20 Common shares (23008) Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.